Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.6300 (-1.86%) ($7.6300 - $7.6300) on Thu. Jan. 26, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.25% (three month average) | RSI | 71 | Latest Price | $7.6300(-1.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 4.3% a day on average for past five trading days. | Weekly Trend | IOVA advances 8.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(50%) IBB(37%) IWC(30%) ARKG(29%) ACES(28%) | Factors Impacting IOVA price | IOVA will decline at least -2.625% in a week (0% probabilities). VIXM(-16%) BND(-10%) UUP(-8%) USO(-8%) XLP(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.625% (StdDev 5.25%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.27(4.95%) | 10 Day Moving Average | $6.83(11.71%) | 20 Day Moving Average | $6.52(17.02%) | To recent high | -21.6% | To recent low | 36% | Market Cap | $1.117b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |